| Literature DB >> 25484304 |
Jennifer Fairlie1, Lea Harrington2.
Abstract
More than 85% of all human cancers possess the ability to maintain chromosome ends, or telomeres, by virtue of telomerase activity. Loss of functional telomeres is incompatible with survival, and telomerase inhibition has been established in several model systems to be a tractable target for cancer therapy. As human tumour cells typically maintain short equilibrium telomere lengths, we wondered if enforced telomere elongation would positively or negatively impact cell survival. We found that telomere elongation beyond a certain length significantly decreased cell clonogenic survival after gamma irradiation. Susceptibility to irradiation was dosage-dependent and increased at telomere lengths exceeding 17kbp despite the fact that all chromosome ends retained telomeric DNA. These data suggest that an optimal telomere length may promote human cancer cell survival in the presence of genotoxic stress.Entities:
Keywords: DNA damage; Gamma irradiation; Human tumour cells; Telomerase; Telomeres
Mesh:
Year: 2014 PMID: 25484304 PMCID: PMC4286114 DOI: 10.1016/j.dnarep.2014.11.005
Source DB: PubMed Journal: DNA Repair (Amst) ISSN: 1568-7856
Fig. 2Tumour cell viability after treatment with ionizing radiation. (A) Independently derived TERT-positive (Vec-1, Vec-2) or TERT-excised lines (Cre-4, Cre-1) (as in Fig. 1A) were subjected to 0–10 Gy ionizing radiation and analyzed for clonogenic survival (see Section 2 for details). (B) A third representative experiment with a TERT-positive (Vec-2) or a TERT-excised line (Cre-1). PDL are indicated in red; average telomere length in blue; n.d. not determined. p-Values (**p < 0.01, ***p < 0.0001) are relative to the earliest PDL at the same irradiation dosage. y-Axis, log10 of the survival fraction; x-axis, dosage of irradiation in Gy. Error bars indicate standard deviation. (C) Plot of survival fraction (SF) as a function of average telomere length, using the data in panel (A) (upper 2 graphs), and (D), plot of the survival fraction (SF) as a function of average telomere length, using the data shown in panel (B), to demonstrate that the maximal SF occurred across a similar range of telomere lengths in independent experimental series.
Fig. 1Telomere length and integrity in human tumour cell lines of varying telomere lengths and TERT status. Four independent clones from the same parental line in which (A) TERT was not excised and cells remained telomerase-positive (TERT-positive; Vec-1, Vec-2) or (B) TERT was excised and cells became telomerase-negative (TERT-excised; Cre-1, Cre-4), were propagated for the population doubling levels indicated (PDL, in red), and quantified for telomere signal intensity using Q-FISH. y-Axis, frequency of events; x-axis, telomere signal intensity in arbitrary units; each tick represents events across 50 a.u. (each 1000 a.u. marked as indicated). The scales for all graphs are equivalent; the y-axis labels are shown only for the top two graphs. Red arrows indicate average telomere length (see Section 2). (C) The percentage of chromosome ends lacking a telomere signal in metaphase preparations (as in A and B). y-Axis, percentage of telomere signal-free ends (total: 920 per sample); x-axis, labels as in (A), with earliest PDL at left. One representative experiment (of n = 3) shown where all samples were analyzed under identical conditions using an automated Metafer system. *p < 0.05, ****p < 0.001 (Fisher's exact test). (D) The incidence of telomere signal-free ends (total n = 920 for all samples) as a function of telomere length. y-Axis, log10 of the incidence of signal-free ends; x-axis, average telomere length in kbp. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)